Prostate-specific antigen decline after casodex withdrawal: Evidence for an antiandrogen withdrawal syndrome
- 31 March 1994
- Vol. 43 (3) , 408-410
- https://doi.org/10.1016/0090-4295(94)90092-2
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.Journal of Clinical Oncology, 1993
- Prostate Specific Antigen Decline after Antiandrogen Withdrawal: the Flutamide Withdrawal SyndromeJournal of Urology, 1993
- Orchiectomy and Nilutamide or Placebo as Treatment of Metastatic Prostatic Cancer in a Multinational Double-Blind Randomized TrialJournal of Urology, 1993
- The Clinical Usefulness of Serum Prostate Specific Antigen After Hormonal Therapy of Metastatic Prostate CancerJournal of Urology, 1992